Neutropenia and myelodysplasia arise from Sbds defects on haematopoietic and osteoprogenitor cells respectively48, therefore correction of hyper-activation of JAK/STAT/mTOR pathways is expected to correct both deficiencies. The gene discussed is SOAT1; the disease is neutropenia.